Nova Patents
NO20022014L

Controlled release hydrocodone formulations

Abstract

The invention is disclosed is a solid oral controlled release dosage-form hydrogen alkone. The dosage-form comprises a salty and by the is controlled release of the analgesic effective quantity's hydrogen capable of the alkone or a pharmaceutically approves, the dosage-form is suitable for the patient and front end of the is two and ground, the dosage-form's the ratio of C12/Cmax is 0.55-0.85, the dosage-form curative effect sustainably at least about 12 method.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

98 members in 21 offices

This recordMember, by publication datePriority claim11 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
16254199United States of AmericaP
0029953United States of AmericaW

Members98

Family members, oldest first
DocumentOfficeKind
CA2389235A1CanadaA1
WO0132148A1World Intellectual Property Organization (WIPO)A1
AU1446501AAustraliaA
NO20022014D0NorwayD0
NO20022014LThis recordNorwayL
KR20020059653ARepublic of KoreaA
EP1227798A1European Patent Office (EPO)A1
MXPA02004293AMexicoA
IL149352A0IsraelA0
HU0203680A2HungaryA2
HUP0203680A2HungaryA2
CN1407884AChinaA
JP2003513032AJapanA
AU764453B2AustraliaB2
HK1054698AHong Kong, ChinaA
HK1054698A1Hong Kong, ChinaA1
AU2003262463A1AustraliaA1
RU2002113921ARussian FederationA
RU2230556C2Russian FederationC2
EP1227798A4European Patent Office (EPO)A4
BR0015284ABrazilA
US2004266807A1United States of AmericaA1
HU0203680A3HungaryA3
HUP0203680A3HungaryA3
KR20050052544ARepublic of KoreaA
AU2003262463B2AustraliaB2
NZ529928ANew ZealandA
EP1623703A1European Patent Office (EPO)A1
HK1087617AHong Kong, ChinaA
HK1087617A1Hong Kong, ChinaA1
JP2007084568AJapanA
CA2389235CCanadaC
KR20080015955ARepublic of KoreaA
KR100889069B1Republic of KoreaB1
KR20100137025ARepublic of KoreaA
IL207613A0IsraelA0
EP2269587A1European Patent Office (EPO)A1
IL149352AIsraelA
IL209703A0IsraelA0
EP2295043A1European Patent Office (EPO)A1
EP2305218A1European Patent Office (EPO)A1
US7943174B2United States of AmericaB2
KR20110106471ARepublic of KoreaA
EP1623703B1European Patent Office (EPO)B1
AT526950TAustriaT
ATE526950T1AustriaT1
US2011262532A1United States of AmericaA1
JP4806507B2JapanB2
DK1623703T3DenmarkT3
PT1623703EPortugalE
ES2374717T3SpainT3
JP2012036199AJapanA
KR20120050528ARepublic of KoreaA
CN1407884BChinaB
CN102716101AChinaA
KR101197919B1Republic of KoreaB1
KR101216270B1Republic of KoreaB1
KR20130010512ARepublic of KoreaA
JP5184774B2JapanB2
NO333380B1NorwayB1
KR20130101157ARepublic of KoreaA
JP2013241461AJapanA
US2014112981A1United States of AmericaA1
JP5536730B2JapanB2
BR0015284B1BrazilB1
BRPI0015284B1BrazilB1
US2014271840A1United States of AmericaA1
KR101476574B1Republic of KoreaB1
US2014377348A1United States of AmericaA1
US8975273B2United States of AmericaB2
US8980291B2United States of AmericaB2
IL207613AIsraelA
IL209703AIsraelA
US9056107B1United States of AmericaB1
US2015174121A1United States of AmericaA1
JP2015131837AJapanA
US2015216809A1United States of AmericaA1
US2015216810A1United States of AmericaA1
CY1112260T1CyprusT1
JP5834052B2JapanB2
US9278074B2United States of AmericaB2
US9320717B2United States of AmericaB2
US2016228429A1United States of AmericaA1
JP2017008089AJapanA
US2017087153A1United States of AmericaA1
US2017136006A1United States of AmericaA1
US2017143697A1United States of AmericaA1
US9669022B2United States of AmericaB2
US9669024B2United States of AmericaB2
US9675611B1United States of AmericaB1
JP6149058B2JapanB2
CN107213128AChinaA
JP6240279B2JapanB2
HU230828B1HungaryB1
US10076516B2United States of AmericaB2
US10179130B2United States of AmericaB2
US2019022086A1United States of AmericaA1
BRPI0015284B8BrazilB8